Lumendi, an English firm, won FDA clearance to introduce its DiLumen Ik endolumenal interventional knife.
The single-use monopolar device is used for surgical dissections, performing cuts, and cauterizing of tissues of the gastrointestinal tract. To help perform many procedures that require a section to be elevated from the surrounding tissue, the same device can be used to administer submucosal fluid injections.
The knife is designed to be compatible with the company’s latest DiLumen C2 Endolumenal Interventional Platform, which positions an endoscope within the large intestine to help perform diagnostic and therapeutic procedures.
“We are responding to the needs of endoscopists by continuing to improve and develop the DiLumen platform of devices,” said Dr. Peter Johann, CEO, Lumendi, in a press release. In addition, we are also developing products and applications for the colon and the upper GI tract with the ultimate goal of reducing and replacing invasive open or laparoscopic surgical procedures.”